Charles River Labs Files 8-K for Financial Results

TL;DR

**Charles River Labs just filed an 8-K to report their latest financial results.**

AI Summary

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed an 8-K on February 14, 2024, to report its results of operations and financial condition, along with related financial statements and exhibits. This filing, under the 1934 Act, indicates the company is disclosing its latest financial performance. The company's business address is 251 Ballardvale Street, Wilmington, Massachusetts 01887.

Why It Matters

This filing informs investors about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s recent financial performance and operational status, providing transparency and crucial data for investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a standard disclosure of financial results, and the filing itself does not inherently present a high risk without the actual content of the results.

Key Players & Entities

• CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (company) — filer
• February 14, 2024 (date) — date of report
• 001-15943 (other) — SEC file number
• 06-1397316 (other) — IRS Employer Identification No.

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common stock, $0.01 par value CRL New York Stock Exchan

Filing Documents

• a53896037.htm (8-K) — 26KB
• a53896037ex99_1.htm (EX-99.1) — 740KB
• 0001157523-24-000238.txt ( ) — 937KB
• crl-20240214.xsd (EX-101.SCH) — 4KB
• crl-20240214_lab.xml (EX-101.LAB) — 22KB
• crl-20240214_pre.xml (EX-101.PRE) — 16KB
• a53896037_htm.xml (XML) — 4KB

02. Results of Operations and Financial Condition

ITEM 2.02. Results of Operations and Financial Condition The following information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On February 14, 2024, Charles River Laboratories International, Inc. issued a press release providing financial results for the fourth quarter and fiscal year ended December 30, 2023. The press release, attached as an exhibit to this report, includes "safe harbor" language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements contained in the press release are "forward-looking" rather than historic. The press release also states that these and other risks relating to Charles River are set forth in the documents filed by Charles River with the Securities and Exchange Commission.

01. Financial Statements and Exhibits

ITEM 9.01. Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Press release dated February 14, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Date: February 14, 2024 By: /s/ Matthew L. Daniel Matthew L. Daniel, Corporate Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR